|
||||||
|
||||||
India Latin America/ Caribbean Africa & Middle East Asia Russia Europe |
|
Our API (Active Pharmaceutical Ingredients) program began in 2006 with a simple objective - facilitating the manufacture of complex formulations, for which, sourcing the API would restrict entry. Over time, we have been able to take the benefits of vertical integration to international markets and our Europian generic subsidiary, Asian, has been able to source the active of several key products to its advantage.
A range of APIs including complex actives like
anticancer, steroids, peptides and hormones are manufactured in dedicated
areas that follow international norms for systems and processes. Complex
APIs, controlled substances, APIs for the regulated markets - all of these
are expected to power our API strategy going ahead.
|
Investor Relations Feedback Contact Worldwide Sitemap | |
Note:-We are committed to helping you find
the right answers to your questions and concerns. However, this web site is not
intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd
products or provide information on which to base medical treatment. If you have
questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a
medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report
adverse drug events. If you are a physician, please follow the procedures
required by your country's regulations.
Please choose one of the given options to contact us and we will respond to your
inquiry as quickly as possible. © 2004 - 2019
Taj Pharmaceuticals Ltd
. All rights reserved